Abstract:Background Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in the metabolism of folate. The non-synonymous single nucleotide polymorphism (nsSNP), C677T (Ala>Val, rs1801133), has been verified to impair enzyme activity. The association with cancer susceptibility, including hepatocellular carcinoma (HCC), has also been widely studied. The results, however, were inconsistent. To shed light on the influence of MTHFR C677T polymorphism on HCC, a meta-analysis was conducted. Methods The meta-analysis of C677T consisted of 10 studies (1814 cases/2862 controls). The association was measured by using random-effect (RE) or fixed-effect (FE) odds ratio (OR) combined with 95% confidence intervals (CIs) according to the studies' heterogeneity. Results Using genetic model analysis, C677T polymorphism was found to increase the risk of HCC in a complete overdominant model, which indicates that heterozygotes CT are at a lesser risk of HCC than either homozygotes CC or TT. Meta-analyses of the 10 studies showed that the TT genotype increased the risk of HCC as compared to the CT genotype: FE OR was 1.20 (95%CI: 1.00-1.45, p for heterogeneity = 0.21). When subgroup analysis was done between the HCC cases and the chronic liver disease (CLD) patients of four studies, meta-analysis showed that individuals with the TT genotype had increased HCC risk compared with those with the CT genotype: FE OR (TT vs. CT) reached 1.81 (1.22-2.71, p for heterogeneity = 0.25). Meanwhile, the C677T polymorphism also increased HCC risk in a recessive model when cases were compared to CLD patients of four studies: RE OR reached 1.85 (95%CI: 1.00-3.42, p for heterogeneity = 0.06). Overall, there was some extent heterogeneity when analyses were performed in various models. There was no publication bias. Conclusion MTHFR C677T polymorphism increased the risk of HCC in an overdominant model, and might be a risk factor for HCC occurrence, especially in CLD patients. The association warranted further studies.

Relevance of Genetic Polymorphism of Methylene Tetrahydrofolate Reductase and Susceptibility to Colonic Cancer: a Meta-analysis

Association Between the MTHFR A1298C Polymorphism and Risk of Cancer: Evidence from 265 Case–control Studies

Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.

Meta-analysis on the Relationship Between MTHFR Gene Polymorphisms and Colorectal Cancer

FOLIC ACID,METHIONINE,AND POLYMORPHISMS OF METHYLENETETRAHYDROFOLATE REDUCTASES AND SUSCEPTIBILITY OF COLORECTAL CANCER

[Association Between Genetic Polymorphisms in Folate Metabolic Enzyme Genes and Colorectal Cancer: a Nested Case-Control Study].

The Polymorphisms in Methylenetetrahydrofolate Reductase, Methionine Synthase, Methionine Synthase Reductase, and the Risk of Colorectal Cancer

A Case-Control Study on the Polymorphisms of Methylenetetrahydrofolate Reductases, Drinking Interaction and Susceptibility in Colorectal Cancer

The 677C>T (rs1801133) Polymorphism in the MTHFR Gene Contributes to Colorectal Cancer Risk: a Meta-Analysis Based on 71 Research Studies.

Relationship of Genetic Polymorphisms in Methylenetetrahydrofolate Reductase and Alcohol Drinking with the Risk of Colorectal Cancer

The Methylenetetrahydrofolate Reductase ( MTHFR ) C677T Polymorphism and Tumor Risk: Evidence from 134 Case–control Studies

Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis

Meta-analysis of the relationship between the Metholenetetrahydrofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer.

Methylenetetrahydrofolate Reductase Polymorphisms and Breast Cancer Risk: a Meta-Analysis from 41 Studies with 16,480 Cases and 22,388 Controls

The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer

Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis

Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population

Association Between the Methylenetetrahydrofolate Reductase C677T Polymorphism and Hepatocellular Carcinoma Risk: a Meta-Analysis

[Association Between Genetic Variations in Methylenetetrahydrofolate Reductase and Risk of Colorectal Cancer in a Chinese Population].

Folate Intake and MTHFR Polymorphism C677T is Not Associated with Ovarian Cancer Risk: Evidence from the Meta-Analysis

MTHFR C677T polymorphism contributes to the risk for gastric cancer